Computed tomography-quantified emphysema distribution is associated with lung function decline

European Respiratory Journal

Volumn 40, Issue 4, 2012, Pages 844-850

  Mohamed Hoesein, Firdaus A A ^a   Van Rikxoort, Eva ^b,c   Van Ginneken, Bram ^b,c   De Jong, Pim A ^a   Prokops, Mathias ^c   Lammers, Jan Willem J ^a   Zanen, Pieter ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Chronic obstructive pulmonary disease; Computed tomography; Emphysema; Lung function decline; Smoking

Indexed keywords

ADULT; ARTICLE; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DISEASE SEVERITY; EMPHYSEMA; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; IMAGE ANALYSIS; LUNG FUNCTION TEST; LUNG INSUFFICIENCY; LUNG LOBE; MAJOR CLINICAL STUDY; MALE; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SMOKING; VOXEL BASED MORPHOMETRY;

AGED; DISEASE PROGRESSION; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LONGITUDINAL STUDIES; LUNG; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; SMOKING; SPIROMETRY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84867115279     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00186311     Document Type: Article

References (35)

1. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997; 349: 1498-1504. (Pubitemid 27216360)
2. Gould GA, MacNee W, McLean A, et al. CT measurements of lung density in life can quantitate distal airspace enlargement-an essential defining feature of human emphysema. Am Rev Respir Dis 1988; 137: 380-392. (Pubitemid 18050189)
3. Gould GA, Redpath AT, Ryan M, et al. Lung CT density correlates with measurements of airflow limitation and the diffusing capacity. Eur Respir J 1991; 4: 141-146.
4. 1-antitrypsin deficiency. Thorax 2006; 61: 485-90.
5. Parr DG, Sevenoaks M, Deng C, et al. Detection of emphysema progression in alpha 1-antitrypsin deficiency using CT densitometry; methodological advances. Respir Res 2008; 9: 21.
6. Mohamed Hoesein FA, de Hoop B, Zanen P, et al. CT-quantified emphysema in male heavy smokers: association with lung function decline. Thorax 2011; 66: 782-787.
7. 1-antitrypsin deficiency influences lung function impairment. Am J Respir Crit Care Med 2004; 170: 1172-1178.
8. Gietema HA, Zanen P, Schilham A, et al. Distribution of emphysema in heavy smokers: impact on pulmonary function. Respir Med 2010; 104: 76-82.
9. van Rikxoort EM, de Hoop B, Viergever MA, et al. Automatic lung segmentation from thoracic computed tomography scans using a hybrid approach with error detection. Med Phys 2009; 36: 2934-2947.
10. van Iersel CA, de Koning HJ, Draisma G, et al. Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer 2007; 120: 868-74. (Pubitemid 46175408)
11. van Klaveren RJ, Oudkerk M, Prokop M, et al. Management of lung nodules detected by volume CT scanning. N Engl J Med 2009; 361: 2221-2229.
12. Miller MR, Crapo R, Hankinson J, et al. General considerations for lung function testing. Eur Respir J 2005; 26: 153-161. (Pubitemid 40945944)
13. Hunninghake GM, Cho MH, Tesfaigzi Y, et al. MMP12, lung function, and COPD in high-risk populations. N Engl J Med 2009; 361: 2599-2608.
14. Gierada DS, Yusen RD, Pilgram TK, et al. Repeatability of quantitative CT indexes of emphysema in patients evaluated for lung volume reduction surgery. Radiology 2001; 220: 448-454. (Pubitemid 32667183)
15. Newell JD Jr, Hogg JC, Snider GL. Report of a workshop: quantitative computed tomography scanning in longitudinal studies of emphysema. Eur Respir J 2004; 23: 769-775. (Pubitemid 38618151)
16. 1-antitrypsin deficiency. Eur Respir J 2005; 25: 23-30.
17. Sverzellati N, Calabro E, Randi G, et al. Sex differences in emphysema phenotype in smokers without airflow obstruction. Eur Respir J 2009; 33: 1320-1328.
18. Gietema HA, Schilham AM, van Ginneken B, et al. Monitoring of smoking-induced emphysema with CT in a lung cancer screening setting: detection of real increase in extent of emphysema. Radiology 2007; 244: 890-897. (Pubitemid 47292102)
19. van Rikxoort EM, de Hoop B, van de Vorst S, et al. Automatic segmentation of pulmonary segments from volumetric chest CT scans. IEEE Trans Med Imaging 2009; 28: 621-630.
20. van Rikxoort EM, Prokop M, de Hoop B, et al. Automatic segmentation of the pulmonary lobes from fissures, airways, and lung borders: evaluation of robustness against missing data. Med Image Comput Comput Assist Interv 2009; 12: 263-271.
21. Coxson HO. Quantitative chest tomography in COPD research: chairman's summary. Proc Am Thorac Soc 2008; 5: 874-877.
22. Coxson HO. Quantitative computed tomography assessment of airway wall dimensions: current status and potential applications for phenotyping chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008; 5: 940-945.
23. Newell JD Jr, Hogg JC, Snider GL. Report of a workshop: quantitative computed tomography scanning in longitudinal studies of emphysema. Eur Respir J 2004; 23: 769-775. (Pubitemid 38618151)
24. Gould GA, MacNee W, McLean A, et al. CT measurements of lung density in life can quantitate distal airspace enlargement-an essential defining feature of human emphysema. Am Rev Respir Dis 1988; 137: 380-392. (Pubitemid 18050189)
25. Joliffe IT, Morgan BJ. Principal component analysis and exploratory factor analysis. Stat Methods Med Res 1992; 1: 69-95.
26. Shaheen SO, Jameson KA, Syddall HE, et al. The relationship of dietary patterns with adult lung function and COPD. Eur Respir J 2010; 36: 277-284.
27. Burgel PR, Paillasseur JL, Caillaud D, et al. Clinical COPD phenotypes: a novel approach using principal component and cluster analyses. Eur Respir J 2010; 36: 531-539.
28. Mair G, Miller JJ, McAllister D, et al. Computed tomographic emphysema distribution: relationship to clinical features in a cohort of smokers. Eur Respir J 2009; 33: 536-542.
29. Gurney JW, Jones KK, Robbins RA, et al. Regional distribution of emphysema: correlation of high-resolution CT with pulmonary function tests in unselected smokers. Radiology 1992; 183: 457-463.
30. Saitoh T, Koba H, Shijubo N, et al. Lobar distribution of emphysema in computed tomographic densitometric analysis. Invest Radiol 2000; 35: 235-243. (Pubitemid 30397163)
31. de Torres JP, Bastarrika G, Zagaceta J, et al. Emphysema presence, severity, and distribution has little impact on the clinical presentation of a cohort of patients with mild to moderate COPD. Chest 2011; 139: 36-42.
32. Demeo DL, Hersh CP, Hoffman EA, et al. Genetic determinants of emphysema distribution in the national emphysema treatment trial. Am J Respir Crit Care Med 2007; 176: 42-48. (Pubitemid 47048053)
33. Ito I, Nagai S, Handa T, et al. Matrix metalloproteinase-9 promoter polymorphism associated with upper lung dominant emphysema. Am J Respir Crit Care Med 2005; 172: 1378-1382. (Pubitemid 43069810)
34. Cockcroft DW, Horne SL. Localization of emphysema within the lung. An hypothesis based upon ventilation/perfusion relationships. Chest 1982; 82: 483-487.
35. Hersh CP, Washko GR, Jacobson FL, et al. Interobserver variability in the determination of upper lobe-predominant emphysema. Chest 2007; 131: 424-431. (Pubitemid 46280402)